- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Patent holdings for IPC class C12Q 1/6886
Total number of patents in this class: 12151
10-year publication summary
|
297
|
410
|
813
|
1152
|
1236
|
1185
|
1269
|
1348
|
1303
|
960
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1153 |
299 |
| The Regents of the University of California | 20172 |
187 |
| Dana-Farber Cancer Institute, Inc. | 2604 |
176 |
| The Johns Hopkins University | 5734 |
170 |
| Guardant Health, Inc. | 454 |
158 |
| Mayo Foundation for Medical Education and Research | 3268 |
142 |
| The General Hospital Corporation | 4784 |
139 |
| Foundation Medicine, Inc. | 371 |
139 |
| The Board of Trustees of the Leland Stanford Junior University | 6500 |
118 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
115 |
| Memorial Sloan-Kettering Cancer Center | 1965 |
114 |
| Board of Regents, The University of Texas System | 5898 |
104 |
| Exact Sciences Corporation | 302 |
96 |
| The Broad Institute, Inc. | 1856 |
93 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2934 |
92 |
| National Cancer Center | 423 |
86 |
| Grail, Inc. | 230 |
85 |
| Genentech, Inc. | 4005 |
82 |
| Centre National de La Recherche Scientifique | 10611 |
76 |
| Toray Industries, Inc. | 7000 |
71 |
| Other owners | 9609 |